Introduction
Carcinogenesis is a multi-step process involving the sequential accumulation of mutations that allow cells to gain a selective growth advantage, have the phenotypic attributes of local invasiveness and the ability to form distant metastasis. At the molecular level, progression results from accumulation of genetic lesions. Chemoprevention is the use of one or several agents to prevent the occurrence of cancer (1, 2) . The mouse skin carcinogenesis model has become very useful in studying the genetic and biological changes involved in tumor promotion (3, 4) . Some of the genetic changes associated with the chemical initiation of benign papillomas and the transition to squamous cell carcinoma have been characterized in this system (5) .
Reactive oxygen species (ROS) have been suggested as causative factors in mutagenesis, carcinogenesis and tumor promotion and have been implicated in the etiology and pathophysiology of many human diseases (6) . They induce strand breaks in DNA, and also oxidative modification of DNA bases leading to mutagenic and carcinogenic effects (7) . They also modulate gene expression by an epigenetic mechanism (8) . Topical application of 12-O-tetradecanoyl-phorbol-13-acetate (TPA) has been reported to increase release of ROS (9) . Many tumor promoters have been shown to exert their action by production of ROS, and many compounds that possess antioxidant activity have been reported to inhibit tumor promotion (10, 11) . ROS induce chromosomal aberrations, structural genetic changes resulting in alterations in gene expression with high efficiency. Thus, they may play an intermediate role in the induction of promotion-related genes.
4Ј-Demethyl epipodophyllotoxin (DMEP, Figure 1 ) is an antimitotic agent which binds to monomeric tubulin, preventing micro-tubule polymerization. The exposure of a dividing cell to DMEP causes the disappearance of the mitotic spindle and blocks the cell in mitosis within a few minutes of exposure to the drug, resulting in cell death (12, 13) . In many cases, the action of preventing microtubule polymerization is reversible, so that removal of the drug allows the spindle to re-form and mitosis to proceed. The disruption of spindle microtubules, which preferentially kills many rapidly dividing cells, allows DMEP to be classified as a potential chemotherapeutic agent (14, 15) .
There is constant search for new drugs that can act as chemotherapeutic agents to treat cancer. In vitro studies in our laboratory have indicated that DMEP exerts its action via apoptosis in cells of myeloid origin (unpublished data). The two-stage mouse skin carcinogenesis model was used in order to test the efficacy of DMEP to prevent the promotional changes that occur during the process of neoplastic development, under in vivo conditions. To the best of our knowledge, this is the first in vivo report on the effect of topical application of DMEP. In the present report we describe the effects of topical application of DMEP on TPA-induced tumor promotion in mouse epidermis previously initiated with 9,10-dimethylbenz[a]anthracene (DMBA). The effects were studied on histopathological changes in mouse skin. The activity of antioxidant enzymes catalase (CAT) and superoxide dismutase (SOD) and the alterations in the levels of glutathione and lipid peroxides in mouse liver and skin were investigated to find out whether DMEP mediates its affect by scavenging free radicals.
Materials and methods

Animals
Male Swiss Albino mice, 4-6 weeks old were used in the study. They were kept in well ventilated polypropylene cages. The mice were fed standard laboratory diet and water ad libitum.
Treatment of the animals for in vivo studies
The backs of the animals were shaved 2 days prior to the start of the experiment. The animals were divided into three groups (n ϭ 10 for each group). Group I animals served as controls. These animals received acetone (200 µl/mouse) application only. Group II animals received two topical applications of 0.24% DMBA in acetone (200 µl/mouse) over a period of 1 week, followed by 5 nmol TPA in acetone (50 µl/mouse) twice weekly for 24 weeks. The mice of group III were treated as Group II mice, except that they were treated with DMEP (200 µl of the solution in acetone at a concentration of 1 µg/ml), 30 min prior to application of the above dose of TPA twice weekly for 24 weeks. (16) . Briefly, thiobarbituric acid (0.8%), sodium dodecyl sulphate (0.1%) and acetic acid (20%) were added to 100 µl of the tissue homogenate (10%) prepared as described above. This mixture was heated for 30 min, cooled, extracted with N-butanol-pyridine, and the OD of MDA recorded at 532 nm. The content of MDA is expressed as nmol/mg protein.
GSH estimation
The level of GSH was estimated by the method of Miron et al. (17) . The proteins were precipitated in the 12 000 g supernatant (obtained as described above) by addition of trichloroacetic acid (TCA) to a final concentration of 5% TCA. This was then centrifuged at 15 000 g for 15 min to obtain the protein free supernatant. To 100 µl of this supernatant, 2 ml of 0.6 M 5,5Ј-dithio-bis(2-nitrobenzoic acid) dissolved in 0.2 M phosphate buffer (pH 8) was added. The absorbance was recorded at 412 nm. Reduced GSH was used as standard. The levels of GSH are expressed as nmol/mg of protein.
SOD assay
This was determined by the method of Misra and Fridovich (18) based upon the ability of SOD to inhibit the auto-oxidation of epinephrine to adrenochrome at alkaline pH. An aliquot of 40 µl of the supernatant of 10% tissue homogenate, obtained as described above, was taken in 0.1 M carbonate buffer (pH 10.2). After addition of epinephrine, the increase in absorbance was measured at 480 nm. The activity of the enzyme is expressed as U/mg of protein, where 1 U of the enzyme is defined as the amount of enzyme required to inhibit the rate of epinephrine auto-oxidation by 50% under the conditions of the assay.
CAT assay
This was assayed by the method of Aebi (19) . The change in absorbance was followed spectrophotometrically at 240 nm after the addition of H 2 O 2 (30 mM) to 100 µl of the supernatant (of 10% tissue homogenate obtained as described above) in 50 mM phosphate buffer (pH 7). The activity of the enzyme is expressed as U/mg of protein, where 1 U is equivalent to 1 mol of H 2 O 2 /µg/min/mg protein.
Protein estimation
This was determined by Bradford assay using bovine serum albumin as a standard (20) .
Statistical analysis
The significance of the difference in the values of GSH, MDA, CAT and SOD was determined using the Kruskal-Wallis test. P-values Ͻ0.05 are considered significant.
Results
Effect of DMEP on DMBA/TPA-induced tumors in Swiss Albino mice
Male Swiss Albino mice (4-6 weeks old) had body weights ranging from 29.6 to 31 g at the beginning of the experiment. The average body weights at the end of the experiment, i.e. 24 weeks, were 48.33 Ϯ 1.41 g in the vehicle-treated, 37.5 Ϯ 3.53 g in the DMBA/TPA-treated and 44.66 Ϯ 1.76 g in DMBA/DMEP/TPA-treated animals ( Figure 2 ). The number of mice bearing tumors in DMBA/TPA-treated and DMBA/DMEP/TPA-treated groups at different weeks is shown in Figure 3 . The onset of tumors (Ͼ2 mm) commenced at 9 weeks in DMBA/TPA-treated mice and reached 100% at 18 weeks, whereas in DMBA/DMEP/TPA-treated mice the Table I ).
Histopathology of mouse skin
The characteristic squamous pearls were clearly visible on examining the H&E-stained sections of the tumors formed on application of DMBA/TPA, i.e. mice belonging to Group II. (Table II) .
The MDA level increased in the liver by 162.93% (P Ͻ 0.05) in animals treated with DMBA/TPA, whereas animals treated with DMBA/DMEP/TPA exhibited an 84.26% increase (P Ͻ 0.05) in the MDA level in the liver with respect to the vehicle-treated control animals. In other words, a 29.92% decrease (P Ͻ 0.05) in the liver MDA level of DMBA/DMEP/ TPA-treated animals was observed as compared with the level in DMBA/TPA-treated animals (Table III) . GSH level. A 38.9% decrease (P Ͻ 0.05) in the levels of GSH in tumors of animals treated with DMBA/TPA, and a 19.2% decrease (P Ͻ 0.05) were observed in the tumors of animals treated with DMBA/DMEP/TPA as compared with vehicletreated control animals (Table II) . There was an average 32.25% increase (P Ͻ 0.05) in the GSH levels in the tumors of animals treated with DMBA/DMEP/TPA in relation to the GSH level in the tumors of animals treated with DMBA/TPA.
In the liver, a decrease of 86.1% (in DMBA/TPA-treated animals; P Ͻ 0.01) and a decrease of 38.2% (in DMBA/ DMEP/TPA-treated animals; P Ͻ 0.05) were observed as compared with vehicle-treated controls in the GSH levels. In general, an increase of 34.4% (P Ͻ 0.05), in the level of GSH was observed in the livers of animals treated with DMBA/ DMEP/TPA in comparison with the animals treated with DMBA/TPA (Table III) . SOD activity. A decrease of 72.3% (P Ͻ 0.001) in the activity of SOD was observed in the tumors of DMBA/TPA-treated animals, whereas animals treated with DMBA/DMEP/TPA exhibited a 59% decrease (P Ͻ 0.001) as compared with controls. There was an average 48% increase (P Ͻ 0.001) in SOD activity in the tumors of animals treated with DMBA/ 999 DMEP/TPA as compared with the level in DMBA/TPA-treated animals (Table II) .
On application of DMBA/TPA, the SOD activity in liver of these animals showed a 53% decrease (P Ͻ 0.01), whereas an 18.9% decrease (P Ͻ 0.01) was observed in the DMBA/DMEP/ TPA-treated animals as compared with controls. However, the activity of SOD in the liver of animals treated with DMBA/ DMEP/TPA showed a 72.58% increase (P Ͻ 0.01) as compared with the SOD activity in the animals treated with DMBA/TPA (Table III) (Table II) .
As compared with vehicle-treated control animals, the activity of CAT in the livers of animals treated with DMBA/TPA showed a 31.2% decrease (P Ͻ 0.01) and a 5.2% decrease (P Ͻ 0.05) in DMBA/DMEP/TPA-treated animals. In general, a 37.83% (P Ͻ 0.05) increase was observed in the animals treated with DMBA/DMEP/TPA as compared with the animals treated with DMBA/TPA (Table III) .
Discussion
Chemoprevention is an important strategy to control the process of carcinogenesis. Thus, there is a need for exploring drugs/ agents which act as chemopreventive agents. In the present study, we have studied the chemopreventive effect of DMEP using a mouse skin carcinogenesis model. Most drugs belonging to the class of podophyllotoxins (e.g. etoposide, teniposide) exert their cytotoxic effect as topoisomerase II 
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inhibitors. DMEP is unique in the class of podophyllotoxins in its mode of action as an inhibitor of microtubule polymerization, thus resembling vinca alkaloids (1) . Given the crucial role of microtubules in chromosome segregation, this pathway provides a means to eliminate cells with aberrant chromosome/DNA damage. In vitro studies in our laboratory illustrated that DMEP caused apoptotic cell death in CML cells (unpublished data). This study shows a significant increase in tumor latency by application of DMEP in Swiss Albino mice initiated by DMBA and promoted by TPA. This may be due to the delay in the promotion phase of carcinogenesis. Along with a decrease in tumor volume (29.2%) by the end of the experiment (24 weeks), significant reduction in the number of tumors formed per mouse was observed (27.5% until the end of week 24). Most in vivo studies using chemopreventive agents, showing significant reduction in the tumor formation, have been followed only until week 20 (21) whereas we followed it until 24 weeks. However, the percentage inhibition was statistically significant until week 21 (47.4%; P Ͻ 0.05) but not at week 24. Even in another in vivo model studied by us, hamster oral pouch carcinogenesis, DMEP increased tumor latency and decreased tumor volume and efficiency of tumor conversion (unpublished data).
Histopathology of the tumors observed 24 weeks after DMBA/TPA treatment showed necrotic keratinised squamous pearls, suggesting invasive squamous cell carcinoma. On the other hand, intact basal cell layer and dysplastic lesions characterized benign papillomas in DMBA/DMEP/TPA-treated animals. This direct evidence shows that DMEP application inhibits the carcinoma formation and conversion efficiency of papillomas into frank squamous cell carcinoma.
In multistep carcinogenesis, reactive oxygen species have been shown to play a role mostly in the promotion phase. Antioxidants are reported to act as protective agents against cancer (22) (23) (24) (25) . The liver is a versatile organ involved in drug metabolism and detoxification, hence the antioxidant enzymes and the other parameters were estimated in liver as well as mouse skin tumors. The reduced form of GSH is a biological antioxidant present in high amounts, especially in the liver, and its presence is a pre-requisite for protection against oxidative damage. This is evident even as seen with DMEP treatment, which protects the losses in GSH levels provoked by DMBA/TPA treatment. The low levels of antioxidant enzymes SOD and CAT in DMBA/TPA-treated mice show poor antioxidant status. Oberley and Oberley (26) have also reported decreased activities of SOD and CAT in squamous cell carcinomas. The increase in antioxidant enzymes by DMEP reflects that it inhibits the process of oxidative stress induced carcinogenesis. Several reports suggest that GSH is a more efficient antioxidant agent than SOD or CAT (27) . GSH alters the profile of lipoxygenase and cyclooxygenase (28, 29) , which are involved in tumorigenesis. Oberley and Oberley (26) reported decreased SOD and CAT activity in papillomas and squamous cell carcinoma leading to a pro-oxidant state of cells, facilitating tumorigenesis. But GSH has been found to be highly variable and contradictory, depending on the cell type, nature of the carcinogen and its modulatory pathways (26, (30) (31) . Increase in the level of GSH by the chemopreventive action of flavonoids in mouse skin has also been reported (32) . It is thus the combined effect of modulating antioxidant enzyme(s), which may in turn lead to a shift in the intracellular oxidation/reduction balance and to a changed cell and organ sensitivity to induced tumorigenesis. During oxidative stress, MDA and/or other aldehydes are formed in biological systems. These can react with amino acids and DNA and introduce cross linkages between proteins and nucleic acids, resulting in alterations in replication, transcription (33) and leading to tumor formation. Elevated levels of MDA were observed in skin tumors as well as in livers of animals treated with DMBA/TPA suggesting oxidative stress in DMBA/TPA-induced mouse skin carcinogenesis. Elangovan et al. (32) also reported an increase in the level of lipid peroxides in the mouse skin model, which were reduced in response to certain flavonoids. Significant decrease in MDA levels by DMEP treatment indicates reduced oxidative stress, thus indicating its protective potential against skin carcinogenesis. This protective effect of DMEP as indicated by reduced lipid peroxides could be due to increase in GSH and the antioxidant enzymes CAT and SOD. The decrease in lipid peroxides may also explain the reduced invasiveness of the tumor as indicated by the histopathology of tumors of DMBA/ DMEP/TPA-treated animals.
DMEP may thus be exerting its chemopreventive effect by acting as an antioxidant. This compound was originally identified as an antitumor agent based on its ability to inhibit microtubule polymerisation. We would like to suggest that other mechanisms may include its capacity to scavenge free radicals, to block or trap ultimate carcinogenic electrophiles by forming innocuous products in a nucleophilic chemical reaction.
